Antiperspirant effect of leaf extract of Myrtuscommunis L.
Phase 3
- Conditions
- Sweating.
- Registration Number
- IRCT20181208041882N17
- Lead Sponsor
- Yazd University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 20
Inclusion Criteria
Informed consent
Volunteers who do not take any other antiperspirant medications or products.
Volunteers between the ages of 18 and 65
Exclusion Criteria
If serious side effects occur
Menopause
Pregnancy
Overweight and obesity
Thyroid disorders
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The amount of perspiration. Timepoint: week 0 and 1. Method of measurement: Visual analog scale.
- Secondary Outcome Measures
Name Time Method